Immediate Management of Allergic Reaction with Shortness of Breath and Rash
Administer intramuscular epinephrine 0.3-0.5 mg (0.01 mg/kg in children, maximum 0.3 mg) into the lateral thigh immediately—this is a life-threatening anaphylactic reaction requiring epinephrine as the only first-line treatment. 1, 2, 3
Recognize This as Anaphylaxis
The combination of shortness of breath (respiratory involvement) plus rash (skin involvement) affecting two organ systems defines anaphylaxis, a potentially fatal systemic allergic reaction. 1, 4, 2
- Anaphylaxis is characterized by: rapid onset of symptoms involving skin (urticaria, angioedema, rash), respiratory tract (dyspnea, wheezing, throat tightness, bronchospasm), and potentially cardiovascular collapse. 1, 4, 5
- The presence of dyspnea with rash indicates at least two organ systems are involved, meeting criteria for severe allergic reaction requiring immediate epinephrine. 1, 2
Immediate Actions (First 5 Minutes)
Step 1: Administer Epinephrine Immediately
- Give 0.3-0.5 mg intramuscular epinephrine (1:1,000 concentration) into the lateral thigh. 1, 6, 3
- In children, dose is 0.01 mg/kg (maximum 0.3 mg). 6, 7
- Epinephrine is life-saving and the only medication proven to reverse all symptoms of anaphylaxis by stabilizing mast cells and preventing progression. 7, 2
- Do not delay epinephrine administration—it should be given as soon as anaphylaxis is suspected, before other interventions. 2, 3, 7
Step 2: Call Emergency Medical Services (911)
- Activate EMS immediately after or while administering epinephrine. 1, 2
- Do not delay EMS activation even if symptoms appear to improve. 1
Step 3: Position the Patient
- Place patient supine (lying flat) with legs elevated unless respiratory distress worsens in this position. 2, 3
- If severe respiratory distress or vomiting, allow patient to sit upright. 3
Secondary Interventions (After Epinephrine)
Only after epinephrine administration, consider adjunct medications: 2, 3
- H1-antihistamine: Diphenhydramine 25-50 mg IV/IM or orally (reduces urticaria and itching but does NOT treat anaphylaxis). 8, 2
- H2-antihistamine: Famotidine or ranitidine (may provide additional benefit for skin symptoms). 1, 2
- Corticosteroids: Prednisone 40-60 mg orally or methylprednisolone 125 mg IV (may prevent biphasic reactions but NOT effective for acute symptoms). 9, 2
- Supplemental oxygen: If available and patient has dyspnea or hypoxemia. 1
- Inhaled beta-2 agonist: Albuterol nebulizer if wheezing persists after epinephrine. 1, 2
Monitoring and Repeat Dosing
- Observe the patient continuously for at least 15 minutes after epinephrine administration. 1
- Repeat epinephrine 0.3-0.5 mg IM every 5-15 minutes if symptoms persist or worsen—18-35% of anaphylaxis cases require a second dose. 1, 2, 3
- Monitor for biphasic reactions (recurrence of symptoms without re-exposure), which can occur 4-12 hours after initial reaction. 2, 3
Critical Pitfalls to Avoid
Common errors that increase mortality: 2, 3, 10
- Delaying epinephrine: Antihistamines and corticosteroids alone are insufficient and dangerous—epinephrine must be first-line. 2, 3, 7
- Using oral/IV epinephrine instead of IM: Intramuscular administration in the lateral thigh provides fastest, most reliable absorption. 3, 7
- Administering epinephrine in wrong location: Avoid deltoid or subcutaneous routes—lateral thigh (vastus lateralis) is the only recommended site. 7
- Discharging too early: Patients require minimum 4-hour observation (up to 12 hours if high-risk features present). 2, 3
- Failing to prescribe epinephrine auto-injector: Only 4.5% of anaphylaxis patients receive discharge prescriptions despite guideline recommendations. 10
Post-Emergency Management
After stabilization and EMS transport: 2, 5
- Document the trigger in medical records if identified (medications, foods, insect stings are most common). 4, 2
- Prescribe two epinephrine auto-injectors (0.3 mg for adults, 0.15 mg for children 15-30 kg) for future reactions. 5, 7
- Refer to allergist/immunologist for trigger identification, allergy testing, and development of emergency action plan. 5, 2
- Provide patient education on allergen avoidance, recognizing early symptoms, and proper auto-injector technique. 5, 2
Special Considerations
- Patients on beta-blockers: May have refractory symptoms requiring glucagon 1-2 mg IV/IM if epinephrine ineffective. 2
- Pregnant patients: Epinephrine is safe and necessary—maternal hypotension poses greater fetal risk than epinephrine. 6
- Cardiovascular disease: Use epinephrine with caution but do NOT withhold—anaphylaxis itself is more dangerous than epinephrine's cardiac effects. 5, 2